Paper17519297
Modafinil augmentation for residual symptoms of fatigue in patients with a partial response to antidepressants.
Lam JY and 2 others. Ann Pharmacother, 2007. Cited by 18 papers, by iCite.
Cite this record
ConductScience Library. Modafinil augmentation for residual symptoms of fatigue in patients with a partial response to antidepressants. Papers, record 17519297. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/17519297
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Modafinil augmentation for residual symptoms of fatigue in patients with a partial response to antidepressants.
- PubMed
Topics7
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antidepressive Agents | Major topic |
| Benzhydryl Compounds | Major topic |
| Central Nervous System Stimulants | Major topic |
| Depression | Major topic |
| Fatigue | Major topic |
| Humans | |
| Modafinil |
Source PubMed
Cited by12
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 18 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 34907284 | Cognitive profiling and proteomic analysis of the modafinil analogue S-CE-123 in experienced aged rats. | Sci Rep | 2021 | https://conductscience.org/library/papers/34907284 | PubMed |
| 32770257 | Behavioral and dopamine transporter binding properties of the modafinil analog (S, S)-CE-158: reversal of the motivational effects of tetrabenazine and enhancement of progressive ratio responding. | Psychopharmacology (Berl) | 2020 | https://conductscience.org/library/papers/32770257 | PubMed |
| 32049857 | Moxibustion at 'Danzhong' (RN17) and 'Guanyuan' (RN4) for fatigue symptom in patients with depression: Study protocol clinical trial (SPIRIT Compliant). | Medicine (Baltimore) | 2020 | https://conductscience.org/library/papers/32049857 | PubMed |
| 31316379 | The Novel Atypical Dopamine Uptake Inhibitor (S)-CE-123 Partially Reverses the Effort-Related Effects of the Dopamine Depleting Agent Tetrabenazine and Increases Progressive Ratio Responding. | Front Pharmacol | 2019 | https://conductscience.org/library/papers/31316379 | PubMed |
| 30209181 | The Psychopharmacology of Effort-Related Decision Making: Dopamine, Adenosine, and Insights into the Neurochemistry of Motivation. | Pharmacol Rev | 2018 | https://conductscience.org/library/papers/30209181 | PubMed |
| 29628879 | Dopamine, Effort-Based Choice, and Behavioral Economics: Basic and Translational Research. | Front Behav Neurosci | 2018 | https://conductscience.org/library/papers/29628879 | PubMed |
| 27189581 | Activational and effort-related aspects of motivation: neural mechanisms and implications for psychopathology. | Brain | 2016 | https://conductscience.org/library/papers/27189581 | PubMed |
| 22043293 | The atypical stimulant and nootropic modafinil interacts with the dopamine transporter in a different manner than classical cocaine-like inhibitors. | PLoS One | 2011 | https://conductscience.org/library/papers/22043293 | PubMed |
| 19783386 | Modafinil does not serve as a reinforcer in cocaine abusers. | Drug Alcohol Depend | 2010 | https://conductscience.org/library/papers/19783386 | PubMed |
| 19565292 | [Neuro-enhancement. Brain doping]. | Nervenarzt | 2009 | https://conductscience.org/library/papers/19565292 | PubMed |
| 19255746 | Depression-like deficits in rats improved by subchronic modafinil. | Psychopharmacology (Berl) | 2009 | https://conductscience.org/library/papers/19255746 | PubMed |
| 19170404 | Sleep disturbances and depression: risk relationships for subsequent depression and therapeutic implications. | Dialogues Clin Neurosci | 2008 | https://conductscience.org/library/papers/19170404 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/17519297
GET https://conductscience.org/api/papers/v1/17519297/authors